TRIM21 and alopecia: Key findings include a later disease onset in men, a higher occurrence of specific antiphospholipid antibodies, severe organ involvement and greater disease damage in men in contrast to a higher occurrence of positive Anti-Ro/SSA-antibodies, photosensitivity, alopecia and Raynaud in women.